Stockscreener 앱 받기
0.51
10.48%
-0.0669
전일 마감가:
$0.5769
열려 있는:
$0.58
하루 거래량:
82,069
Relative Volume:
0.83
시가총액:
$10.11M
수익:
$9.15M
순이익/손실:
$-16.18M
주가수익비율:
-0.2898
EPS:
-1.76
순현금흐름:
$-15.92M
1주 성능:
-26.22%
1개월 성능:
-31.12%
6개월 성능:
-68.12%
1년 성능:
-89.46%
1일 변동 폭
$0.5007
$0.5801
1주일 범위
$0.5134
$0.68
52주 변동 폭
$0.5134
$5.65
Aspira Womens Health Inc Stock (AWH) Company Profile
명칭
Aspira Womens Health Inc
전화
512-519-0400
주소
12117 BEE CAVES ROAD BUILDING THREE, AUSTIN
AWH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AWH
Aspira Womens Health Inc
|
0.5007 | 10.11M | 9.15M | -16.18M | -15.92M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
560.90 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
241.00 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
146.44 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
198.13 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
428.88 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Aspira Womens Health Inc Stock (AWH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-01-12 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-03-29 | 개시 | Truist | Buy |
| 2021-01-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-30 | 개시 | William Blair | Outperform |
Aspira Womens Health Inc 주식(AWH)의 최신 뉴스
Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, a - Defense World
Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com - Defense World
Aspira Women’s Health Appoints Mike Buhle as SVP of Commercial Operations - citybiz
Aspira Women's Health Inc. Appoints Mike Buhle as SVP of Commercial Operations - Marketscreener.com
Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations - AccessWire
Aspira Women's Health CFO resigns, CEO assumes duties - Investing.com
Aspira Women’s Health CFO Resignation and Leadership Update - TipRanks
AWH Stock Surges Over 5% Amid Mixed Analyst Ratings - GuruFocus.com
Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com - Defense World
Aspira Women's Health in Shelton to use $10M grant to create blood test to detect endometriosis - CTPost
Aspira Women’s Health (NASDAQ:AWH) Earns Hold Rating from Analysts at StockNews.com - Defense World
Organon & Co. (NYSE: OGN) Reduces Board Size Following Resignation of Director - Defense World
Aspira Women's Health's SWOT analysis: stock outlook amid diagnostic growth - Investing.com Nigeria
Aspira Women's Health CEO steps down, interim appointed By Investing.com - Investing.com Canada
Aspira Women’s Health CEO Transition and Leadership Change - TipRanks
AWHAspira Women's Health Inc. Latest Stock News & Market Updates - StockTitan
Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer - citybiz
Aspira Women’s Health Appoints Dr. Sandra Milligan as Interim CEO - citybiz
Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan
Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO - The Manila Times
Aspira Women's Health CEO Steps Down Following OvaWatch Launch, $10M Research Grant Success - StockTitan
StockNews.com Begins Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World
Aspira Women's Health's SWOT analysis: stock faces growth potential amid financial hurdles - Investing.com Nigeria
CURE® SURVEY UNVEILS WHAT INVESTORS LOOK FOR IN FUNDING WOMEN'S HEALTH - PR Newswire
AWS supports ARPA-H Sprint for Women’s Health to advance crucial research and solutions - AWS Blog
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award - The Manila Times
Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test - StockTitan
StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World
Aspira: Q3 Earnings Snapshot - New Haven Register
Aspira Women's Health Inc. (AWH) reports earnings - Quartzy
Aspira Women's Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Aspira Women’s Health Inc. (NASDAQ:AWH) Q3 2024 Earnings Call Transcript - MSN
Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... - Yahoo Finance
Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... By GuruFocus - Investing.com Canada
Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances - TipRanks
ARMISTICE CAPITAL, LLC Expands Stake in Aspira Womens Health Inc - GuruFocus.com
Aspira Women’s Health reports Q3 revenue $2.3M, consensus $2.73M - TipRanks
Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results - The Manila Times
Aspira Women's Health Q3: OvaWatch Grows 27%, Secures $10M Federal Contract | AWH Stock News - StockTitan
Aspira Women's Health Inc (AWH) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated by Analysts at StockNews.com - Defense World
Aspira Women?s Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch - Marketscreener.com
Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® - The Manila Times
Aspira Women's Health Expands BioReference Partnership, Reaches 15M+ Women With OvaWatch | AWH Stock News - StockTitan
FDA's LDT RULE: Steps to Prepare for Your FDA 1st Milestone SubmissionDARKDaily.com - DARKDaily.com - Laboratory News
Aspira Womens Health Inc (AWH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aspira Womens Health Inc 주식 (AWH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Fralick Celeste Rachelle | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,000 |
0 |
50,665 |
| Parnell Winfred | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,157 |
0 |
60,897 |
| Cavanaugh Stefanie L. | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,937 |
0 |
66,851 |
| Ragard John Phillip | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
4,844 |
0 |
125,047 |
| Milligan Sandra | Interim CEO & President |
Dec 31 '24 |
Option Exercise |
0.00 |
20,000 |
0 |
20,000 |
| Vos Ellen O'Connor | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
5,312 |
0 |
63,364 |
| Vos Ellen O'Connor | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,313 |
0 |
58,052 |
| Cavanaugh Stefanie L. | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,938 |
0 |
60,914 |
| Parnell Winfred | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
5,156 |
0 |
55,740 |
| Herchuk Jannie Prestridge | Director |
Sep 30 '24 |
Option Exercise |
0.00 |
8,438 |
0 |
57,190 |
0.97%
자본화:
|
볼륨(24시간):